Peptide Vaccination Against Cytomegalovirus Induces Specific T Cell Response in Responses in CMV Seronegative End-Stage Renal Disease Patients
Introduction: Cytomegalovirus (CMV) reactivation occurs in seronegative patients after solid organ transplantation (SOT) particularly from seropositive donors and can be lethal. Generation of CMV-specific T cells helps to prevent CMV reactivation. Therefore, we initiated a clinical phase I CMVpp65 p...
Main Authors: | Claudia Sommerer, Anita Schmitt, Angela Hückelhoven-Krauss, Thomas Giese, Thomas Bruckner, Lei Wang, Paul Schnitzler, Stefan Meuer, Martin Zeier, Michael Schmitt |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/2/133 |
Similar Items
-
The Value of Persistent Cytomegalovirus Infection in the Formation of Groups of Children with Recurrent Acute Respiratory Diseases
by: I. A. Sotnikov, et al.
Published: (2015-12-01) -
Comparison of Antigenemia and Quantitative DNA Assay in Cytomegalovirus Disease
by: Ayşın ZEYTİNOĞLU, et al.
Published: (2002-12-01) -
Clinical Development of a Cytomegalovirus DNA Vaccine: From Product Concept to Pivotal Phase 3 Trial
by: Michele Gerber, et al.
Published: (2013-09-01) -
Cytomegalovirus infection in primiparous pregnant women and their neonates
by: "Siadati A, et al.
Published: (2002-07-01) -
Cytomegalovirus infection in primiparous pregnant women and their neonates
by: "Siadati A, et al.
Published: (2002-09-01)